U.S. federal trademark · Serial No. 88811294
Pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of immune disorders; pharmaceutical preparations for immunotherapy through genetically engineered cell therapy; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of cancer and tumors for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of immune disorders for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of cancer and tumors for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of immune disorders for medical or clinical purposes; biological and pharmaceutical preparations for the treatment of cancer and immune disorders using genetically engineered cells
Business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of cancer and tumors; business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of immune disorders; pharmaceutical sales promotion for others
Pharmaceutical research and development; medical and scientific research and development of cellular immunotherapies for the treatment of cancer and tumors; medical and scientific research and development of cellular immunotherapies for the treatment of immune disorders; conducting clinical trials for others regarding pharmaceutical preparations and drugs in the field of immunotherapy and cell therapy; scientific and technological services, namely, research, analysis, and clinical trials for others in the field of cellular immunotherapy; providing medical and scientific research information in the field of cellular immunotherapies; compiling scientific and or clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of cell therapy, genetics, immunology, rare diseases, and oncology; licensing of technology in the fields of pharmaceuticals and gene therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.